Argiris, A., Ghebremichael, M., Burtness, B., Axelrod, R. S., Deconti, R. C., & Forastiere, A. A. (2011). A phase II trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: A trial of the Eastern Cooperative Oncology Group (E1303).

Argiris, Athanassios, Musie Ghebremichael, Barbara Burtness, Rita S. Axelrod, Ronald C. Deconti, e Arlene A. Forastiere. A Phase II Trial of Bortezomib Followed By the Addition of Doxorubicin At Progression in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck: A Trial of the Eastern Cooperative Oncology Group (E1303). 2011.

Argiris, Athanassios, et al. A Phase II Trial of Bortezomib Followed By the Addition of Doxorubicin At Progression in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck: A Trial of the Eastern Cooperative Oncology Group (E1303). 2011.